Chiropractors in South Charleston, WV Accepting Medicare

8 Chiropractors found. Showing 1 - 8

Mr. Brett A Morgan, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 135 7th Ave, South Charleston, WV 25303 Phone: 304-768-6106    Fax: 304-768-6491

Dr Morgans Complete Health Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4834 Maccorkle Avenue Sw, South Charleston, WV 25309 Phone: 304-768-6106    Fax: 304-720-2049

Dr. William V. Jordan, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 411 D. Street, South Charleston, WV 25303 Phone: 304-768-7671    Fax: 304-768-6491

Erica Adair Gibson, DC, ATC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 135 7th Ave, South Charleston, WV 25303 Phone: 304-768-6106    Fax: 304-746-0608

Dr. John Paul Tupta, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 424 Division St, South Charleston, WV 25309 Phone: 681-265-2090    Fax: 681-265-2091

Joshua Morgan, DC Chiropractor - Orthopedic Medicare: Medicare Enrolled Practice Location: 4008 Maccorkle Ave Sw, South Charleston, WV 25309 Phone: 304-400-4056

Jordan Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4024 Maccorkle Ave Sw, South Charleston, WV 25309 Phone: 304-768-7671

Back 2 Life Chiropractic Pllc Chiropractor - Orthopedic Medicare: Medicare Enrolled Practice Location: 4008 Maccorkle Ave Sw, South Charleston, WV 25309 Phone: 304-400-4056

News Archive

Amarantus BioScience Holdings closes $3M investment

Amarantus BioScience Holdings, Inc., a biotechnology company developing products in Regenerative Medicine, Neurology and Orphan diseases, today announced the closing of a $3M investment from an institutional investor. Under the terms of the agreement, the investor will be issued $3.3M worth of Series H Convertible Preferred Stock (including 10% original issue discount) from the Company and five year warrants exercisable for 13,200,000 shares of common stock at $0.40 per share.

Akebia completes enrollment in ongoing 200-patient Phase 2b study of AKB-6548

Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced it has completed enrollment in its ongoing 200-patient Phase 2b study of AKB-6548 for the treatment of anemia associated with chronic kidney disease (CKD) in patients who are not dependent on dialysis.

FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone

Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has notified CTI that a Prescription Drug User Fee Act (PDUFA) action date of April 23, 2010 under standard review has been established regarding CTI's NDA for pixantrone as potential treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL).

Wine harder on the brain than beer

Scientists say wine damages the brain more than beer or spirits, because it particularly affects the hippocampus, the part of the brain associated with memory and spatial awareness.

New research results reveal that two Parkinson genes can maintain the mitochondrial functions

Parkinson's disease is caused by the degeneration of neurons in the midbrain. The mechanisms leading to the loss of these neurons, however, are largely unknown. Recent research revealed that about ten per cent of cases are caused by defects in so-called Parkinson-associated genes. Furthermore, mitochondria, the cellular powerhouses, seem to play a major role. New results from researchers at the LMU Munich under the lead of associate professor Dr. Konstanze Winklhofer and Professor Christian Haass connect both phenomena, showing that two Parkinson genes maintain the function of mitochondria.

Read more Medical News

› Verified 5 days ago